2 terminated, 1 not yet recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Not yet recruiting 1 |
Follow arsenous acid: new trials by email Literature Review of arsenous acid trials Research Report on arsenous acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome Allogeneic Hematopoietic Stem Cell Transplantation, Arsenic Trioxide, Biospecimen Collection - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Not yet recruiting | University of Michigan Rogel Cancer Center | 20 | 2026-11-01 | 2026-07-30 |
| Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis Arsenic Trioxide, Ascorbic Acid, Laboratory Biomarker Analysis - Essential Thrombocythemia, Polycythemia Vera | Phase 1 | Terminated | Roswell Park Cancer Institute | 5 | 2010-04-01 | 2022-07-22 |
| Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy Disulfiram, Arsenic trioxide - Metastatic Melanoma | Phase 1 | Terminated | University of California, Irvine | 9 | 2006-09-01 | 2019-08-07 |
Leukemia, Myeloid, Acute (1) · Melanoma (1) · Myelodysplastic Syndromes (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1)
Roswell Park Cancer Institute (1) · University of California, Irvine (1) · University of Michigan Rogel Cancer Center (1)
United States (3)
Eunice Wang, MD (1) · John M Magenau (1) · John P Fruehauf, M.D. PhD (1)